Latest News & Features
Americas
India-based pharmaceutical company Glenmark has signed a wide-ranging drug agreement with Particle Sciences, a provider of drug development services. 27 September 2016
Americas
Healthcare company Fresenius Kabi has won a preliminary injunction in a patent infringement lawsuit against a rival company. 27 September 2016
Americas
The US Food and Drug Administration has approved a biosimilar application by pharmaceutical company Amgen, the fourth such product to be rubberstamped in the country. 26 September 2016
Americas
Law firm White & Case has hired Charles Larsen as a partner in its global intellectual property practice in Boston. 23 September 2016
Americas
Japan-based Otsuka Pharmaceutical has targeted three companies in a patent infringement lawsuit. 22 September 2016
Africa
Teva and Regeneron Pharmaceuticals have combined to develop and commercialise fasinumab, a novel nerve growth factor (NGF) antibody. 22 September 2016
Americas
Allergan has entered into an agreement to acquire Tobira Therapeutics for up to $1.7 billion. 22 September 2016
Americas
Sanofi has filed a complaint against Merck for allegedly infringing ten of its patents centring on the diabetes drugs Lantus and Lantus SoloSTAR. 21 September 2016
Europe
A decision by Germany’s Federal Court of Justice has developed the concept of the ‘doctrine of equivalents’, possibly benefiting pharma patent owners, say Bernd Allekotte and Markus Grammel of Grünecker. 20 September 2016
Americas
Pharmaceutical pay-for-delay deals worth less than around $10 million are unlikely to be challenged by the authorities in US courts, according to a speaker at the 2016 AIPPI World Congress in Milan. 20 September 2016